产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 99% | 询价 | |||
| 5mg | 99% | 询价 | |||
| 10mg | 99% | 询价 | |||
| 25mg | 99% | 询价 | |||
| 50mg | 99% | 询价 | |||
| 100mg | 99% | 询价 | |||
| 250mg | 99% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 99% | 询价 | |||
| 5mg | 99% | 询价 | |||
| 10mg | 99% | 询价 | |||
| 25mg | 99% | 询价 | |||
| 50mg | 99% | 询价 | |||
| 100mg | 99% | 询价 | |||
| 250mg | 99% | 询价 |
CAS No. |
1799974-70-1 |
|---|---|
中文名称 |
(S)-3-(7-甲氧基-1-甲基-1H-苯并[d] [1,2,3]三唑-5-基)-3-(4-甲基-3-((R)-4-甲基-1,1-二氧代-3,4-二氢-2H-苯并[b] [1,4,5]氧硫氮杂卓-2-基)甲基)苯基)丙酸 |
英文名称 |
(S)-3-(7-Methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid |
别名 |
KI-696;1H-Benzotriazole-5-propanoic acid, β-[3-[[(4R)-3,4-dihydro-4-methyl-1,1-dioxido-2H-5,1,2-benzoxathiazepin-2-yl]methyl]-4-methylphenyl]-7-methoxy-1-methyl-, (βS)-;KI-696,KI696;(S)-3-(7-Methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid;KI696, 10 mM in DMSO;CAS:1799974-70-1;(3S)-3-(7-methoxy-1-methylbenzotriazol-5-yl)-3-[4-methyl-3-[[(4R)-4-methyl-1,1-dioxo-3,4-dihydro-5,1lambda6,2-benzoxathiazepin-2-yl]methyl]phenyl]propanoic acid |
标准英文名 |
(S)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid |
分子式 |
C28H30N4O6S |
分子量 |
550.64 |
精确分子量 |
550.19 |
SMILES |
O=C(O)C[C@@H](C1=CC=C(C)C(CN(C[C@@H](C)OC2=CC=CC=C23)S3(=O)=O)=C1)C4=CC(OC)=C(N(C)N=N5)C5=C4 |
标准SMILES |
CN1N=NC2=CC(=CC(OC)=C12)[C@@H](CC(O)=O)C1C=C(CN2C[C@@H](C)OC3=CC=CC=C3S2(=O)=O)C(C)=CC=1 |
性状 |
Solid |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
ZDNGJXBUEQNFBQ-GCJKJVERSA-N |
危险类别(旧) |
H302,H315,H319,H335 |
存储要求 |
Sealed in dry,2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A),Specific target organ toxicity, single exposure; Respiratory tract irritation (Category 3) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|